BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29112769)

  • 1. Dynamic changes of the composition of plasma HDL particles in patients with cardiac disease: Spotlight on sphingosine-1-phosphate/serum amyloid A ratio.
    Egom EE; Shiwani HA; Pharithi RB; Canning R; Khan B; Hiani YE; Maher V
    Clin Exp Pharmacol Physiol; 2018 Apr; 45(4):319-325. PubMed ID: 29112769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P).
    Potì F; Simoni M; Nofer JR
    Cardiovasc Res; 2014 Aug; 103(3):395-404. PubMed ID: 24891400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality.
    Prüfer N; Kleuser B; van der Giet M
    Biol Chem; 2015 Jun; 396(6-7):573-83. PubMed ID: 25252751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL quality or cholesterol cargo: what really matters--spotlight on sphingosine-1-phosphate-rich HDL.
    Egom EE; Mamas MA; Soran H
    Curr Opin Lipidol; 2013 Aug; 24(4):351-6. PubMed ID: 23652570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins.
    Zhang B; Tomura H; Kuwabara A; Kimura T; Miura S; Noda K; Okajima F; Saku K
    Atherosclerosis; 2005 Jan; 178(1):199-205. PubMed ID: 15585219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of apolipoprotein M and sphingosine 1-phosphate axis in the prevention of atherosclerosis].
    Nádró B; Juhász L; Szentpéteri A; Páll D; Paragh G; Harangi M
    Orv Hetil; 2018 Feb; 159(5):168-175. PubMed ID: 29376427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.
    Brinck JW; Thomas A; Brulhart-Meynet MC; Lauer E; Frej C; Dahlbäck B; Stenvinkel P; James RW; Frias MA
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29178180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
    Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study.
    Soria-Florido MT; Castañer O; Lassale C; Estruch R; Salas-Salvadó J; Martínez-González MÁ; Corella D; Ros E; Arós F; Elosua R; Lapetra J; Fiol M; Alonso-Gómez A; Gómez-Gracia E; Serra-Majem L; Pintó X; Bulló M; Ruiz-Canela M; Sorlí JV; Hernáez Á; Fitó M
    Circulation; 2020 Feb; 141(6):444-453. PubMed ID: 31941372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
    Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
    Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of Sphingosine-1-Phosphate in Human Plasma Using Liquid Chromatography Coupled with Q-Tof Mass Spectrometry.
    Egom EE; Fitzgerald R; Canning R; Pharithi RB; Murphy C; Maher V
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum amyloid A does not affect high-density lipoprotein cholesterol measurement by a homogeneous assay.
    Sato M; Ohkawa R; Low H; Nishimori M; Okubo S; Yoshimoto A; Yano K; Kameda T; Yatomi Y; Tozuka M
    Clin Biochem; 2019 Jan; 63():97-101. PubMed ID: 30342019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.
    van Eijk IC; de Vries MK; Levels JH; Peters MJ; Huizer EE; Dijkmans BA; van der Horst-Bruinsma IE; Hazenberg BP; van de Stadt RJ; Wolbink GJ; Nurmohamed MT
    Arthritis Rheum; 2009 May; 60(5):1324-30. PubMed ID: 19404933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.
    Frias MA; Thomas A; Brulhart-Meynet MC; Kövamees O; Pernow J; Eriksson M; Angelin B; James RW; Brinck JW
    Eur J Clin Invest; 2017 Jan; 47(1):38-43. PubMed ID: 27861771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCA1, ABCG1, and SR-BI: Transit of HDL-associated sphingosine-1-phosphate.
    Liu X; Xiong SL; Yi GH
    Clin Chim Acta; 2012 Feb; 413(3-4):384-90. PubMed ID: 22115863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans.
    Soltau I; Mudersbach E; Geissen M; Schwedhelm E; Winkler MS; Geffken M; Peine S; Schoen G; Debus ES; Larena-Avellaneda A; Daum G
    PLoS One; 2016; 11(12):e0168302. PubMed ID: 27973607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
    Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
    Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lipid composition on the structural properties of human serum amyloid A in reconstituted high-density lipoprotein particles.
    Takase H; Tanaka M; Nakamura Y; Morita SY; Yamada T; Mukai T
    Chem Phys Lipids; 2019 Jul; 221():8-14. PubMed ID: 30836067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection.
    Sattler K; Levkau B
    Cardiovasc Res; 2009 May; 82(2):201-11. PubMed ID: 19233866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.
    Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A
    Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.